ES2140552T3 - Derivados indol como inhibidores de la 5-alfa-reductasa-1. - Google Patents

Derivados indol como inhibidores de la 5-alfa-reductasa-1.

Info

Publication number
ES2140552T3
ES2140552T3 ES94924836T ES94924836T ES2140552T3 ES 2140552 T3 ES2140552 T3 ES 2140552T3 ES 94924836 T ES94924836 T ES 94924836T ES 94924836 T ES94924836 T ES 94924836T ES 2140552 T3 ES2140552 T3 ES 2140552T3
Authority
ES
Spain
Prior art keywords
sub
reductase
alpha
inhibitors
indol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924836T
Other languages
English (en)
Inventor
Julian Blagg
Graham Nigel Maw
David James Rawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research and Development Co NV SA filed Critical Pfizer Research and Development Co NV SA
Application granted granted Critical
Publication of ES2140552T3 publication Critical patent/ES2140552T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/307—Compounds having groups having acetal carbon atoms bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/313—Compounds having groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/784—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic with all keto groups bound to a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE LA FORMULA (I) Y LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS MISMOS, EN DONDE R ES CO{SUB,2}R12 Y R12 ES H O UN GRUPO FORMADOR DE UN ESTER BIOLABIL O R ES TETRAZOL-5-IL Y BIEN (A) R1 ES (IA) Y R2 ES F, CL, BR, I, CH{SUB,3} O CF{SUB,3} O (B) R1 ES ALQUILO C{SUB,3-6} Y R2 ES ALQUILO C{SUB,2-4}, LOS COMPUESTOS SON INHIBIDORES SELECTIVOS DE LA 5-ALFA-REDUCTASA-1.
ES94924836T 1993-08-17 1994-08-02 Derivados indol como inhibidores de la 5-alfa-reductasa-1. Expired - Lifetime ES2140552T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317096A GB9317096D0 (en) 1993-08-17 1993-08-17 Indoles

Publications (1)

Publication Number Publication Date
ES2140552T3 true ES2140552T3 (es) 2000-03-01

Family

ID=10740625

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924836T Expired - Lifetime ES2140552T3 (es) 1993-08-17 1994-08-02 Derivados indol como inhibidores de la 5-alfa-reductasa-1.

Country Status (18)

Country Link
US (1) US5912357A (es)
EP (1) EP0714390B1 (es)
JP (1) JP2833865B2 (es)
AT (1) ATE188695T1 (es)
AU (1) AU7497794A (es)
CA (1) CA2167397C (es)
CO (1) CO4290297A1 (es)
DE (1) DE69422629T2 (es)
DK (1) DK0714390T3 (es)
EC (1) ECSP941143A (es)
ES (1) ES2140552T3 (es)
FI (1) FI960730A (es)
GB (1) GB9317096D0 (es)
GR (1) GR3032845T3 (es)
IL (1) IL110627A0 (es)
PE (1) PE16695A1 (es)
PT (1) PT714390E (es)
WO (1) WO1995005375A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
FR2796279B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9115951D0 (en) * 1991-07-24 1991-09-11 Pfizer Ltd Indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
JP2833865B2 (ja) 1998-12-09
US5912357A (en) 1999-06-15
PT714390E (pt) 2000-06-30
CA2167397A1 (en) 1995-02-23
DE69422629T2 (de) 2000-06-29
DK0714390T3 (da) 2000-05-01
FI960730A0 (fi) 1996-02-16
ATE188695T1 (de) 2000-01-15
CA2167397C (en) 2000-12-12
GR3032845T3 (en) 2000-07-31
IL110627A0 (en) 1994-11-11
ECSP941143A (es) 1995-01-16
PE16695A1 (es) 1995-06-21
WO1995005375A1 (en) 1995-02-23
EP0714390A1 (en) 1996-06-05
EP0714390B1 (en) 2000-01-12
FI960730A (fi) 1996-02-16
CO4290297A1 (es) 1996-04-17
DE69422629D1 (en) 2000-02-17
JPH09500142A (ja) 1997-01-07
GB9317096D0 (en) 1993-09-29
AU7497794A (en) 1995-03-14

Similar Documents

Publication Publication Date Title
DK0771794T3 (da) Oxygenholdige heterocykliske forbindelser
EA199900531A1 (ru) Хинолиновые и хиназолиновые соединения, применяемые в терапии, особенно при лечении доброкачественной гиперплазии простаты
PT887344E (pt) Quinolinas e quinazolinas uteis em terapia
UY25987A1 (es) Procedimiento para preparar complejo del inhibidor de ras-fa rnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2- hidroxipropil-beta-ciclodextrina y método
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
IS4206A (is) Hliðstæðar aðferðir til framleiðslu á andróstenónafleiðu og milliefni notuð í aðferðunum
EA199800987A1 (ru) Бензоксазиноновые антагонисты рецептора допамина d4
MY113518A (en) Benzothiazolone derivatives
DK160098C (da) Tricycliske oxindolcarboxamid-derivater
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
ES2182090T3 (es) Nuevos derivados de pirrol.
CO5011097A1 (es) Derivados de 8-azabiciclo [3.2.1]octan-3-metanamina .
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
DK145286D0 (da) Bicyclooctanderivater
DK369289A (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
ES2169909T3 (es) 5-hidroximetil-2-aminotetralinas como agentes cardiovasculares.
ES2170802T3 (es) Carboxamidas biciclicas como ligandos de los receptores 5-ht1a.
DE3887426T2 (de) Eperisone als Hypotonikum.
CO4970778A1 (es) Nuevos compuestos
CO4180556A1 (es) Esteres-amidas de acidos carboxilicos heterociclicos sustituidos y metodo para prepararlos
IT1271703B (it) "derivati 6-o 7-sostituiti del 4-aminoandrostadienone e procedimento per la loro preparazione"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 714390

Country of ref document: ES